Nomura Holdings Inc Adverum Biotechnologies, Inc. Transaction History

Nomura Holdings Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 18, 2022	SELL	$1.23 - $1.95 $232,612 - $368,776	-189,116 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.74 - $2.4 $329,061 - $453,878	189,116 New	189,116 $332,000
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $314,880 - $456,320	-32,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.3 - $21.64 $223,746 - $470,085	21,723 Added 211.37%	32,000 $334,000
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $415,607 - $1.25 Million	-48,723 Reduced 82.58%	10,277 $214,000
Q1 2020 May 14, 2020	BUY	$7.98 - $16.32 $470,820 - $962,880	59,000 New	59,000 $585,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.